Kidswell Bio Corporation (TYO:4584)
Japan · Delayed Price · Currency is JPY 147.00
-3.00 (-2.00%)
Aug 6, 2026, 2:04 PM JST
Kidswell Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Net Income | -402 | 72 | -533 | -999 | -7,314 |
Depreciation & Amortization | - | - | 2 | - | - |
Loss (Gain) From Sale of Assets | - | 6 | - | 1 | 5,982 |
Loss (Gain) From Sale of Investments | 15 | -35 | -417 | 7 | -4 |
Other Operating Activities | -145 | -5 | -1 | -2 | -3 |
Change in Accounts Receivable | 536 | -385 | 354 | -174 | -89 |
Change in Inventory | 986 | -599 | -538 | -196 | -101 |
Change in Accounts Payable | -64 | 56 | -171 | 265 | -207 |
Change in Other Net Operating Assets | -2,022 | 1,826 | 135 | -169 | 411 |
Operating Cash Flow | -1,096 | 936 | -1,169 | -1,267 | -1,325 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Capital Expenditures | -17 | -6 | - | - | -1 |
Cash Acquisitions | - | - | - | - | 12 |
Divestitures | - | - | - | -14 | - |
Sale (Purchase) of Intangibles | - | - | - | -3 | - |
Investment in Securities | - | 74 | 526 | - | -94 |
Other Investing Activities | 5 | -3 | - | -5 | -4 |
Investing Cash Flow | -12 | 65 | 526 | -22 | -137 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Long-Term Debt Issued | 2,500 | - | - | 599 | 1,181 |
Total Debt Issued | 2,500 | - | - | 599 | 1,181 |
Short-Term Debt Repaid | - | - | - | -25 | - |
Long-Term Debt Repaid | -1,413 | -748 | - | - | - |
Total Debt Repaid | -1,413 | -748 | - | -25 | - |
Net Debt Issued (Repaid) | 1,087 | -748 | - | 574 | 1,181 |
Issuance of Common Stock | 310 | 508 | 369 | 143 | 43 |
Other Financing Activities | - | - | - | 1 | -3 |
Financing Cash Flow | 1,397 | -240 | 369 | 718 | 1,221 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Foreign Exchange Rate Adjustments | 10 | 2 | - | - | - |
Miscellaneous Cash Flow Adjustments | - | 1 | 1 | - | 264 |
Net Cash Flow | 299 | 764 | -273 | -571 | 23 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Free Cash Flow | -1,113 | 930 | -1,169 | -1,267 | -1,326 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -16.89% | 18.30% | -74.51% | -127.21% | -123.12% |
Free Cash Flow Per Share | -22.81 | 22.96 | -37.89 | -44.01 | -47.97 |
Levered Free Cash Flow | -849.5 | - | -895.75 | -954.63 | -753.19 |
Unlevered Free Cash Flow | -818.88 | - | -886.38 | -945.25 | -750.06 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash Interest Paid | 41 | 46 | 15 | 15 | 5 |
Cash Income Tax Paid | 151 | 1 | 1 | 2 | 2 |
Change in Working Capital | -564 | 898 | -220 | -274 | 14 |